Melvin I Fox

1PUBLICATIONS
3CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 28, 2017
Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells.

Shiming Ye, Melvin I Fox, Nicole A Belmar

Pageof 1

Frequent Collaborators

1 joint publications

Shiming Ye

1 joint publications

Debra T Chao

1 joint publications

Gary C Starling